Yonova-Doing E, Atadzhanov M, Quadri M, Kelly P, Shawa N, Musonda ST, Simons EJ, Breedveld GJ, Oostra BA, Bonifati V (2012) Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinsons disease
Published by Eli Lilly in December 2025, the results showed: Average weight loss of 28.7% at the 12mg dose over 68 weeks comparable to TRIUMPH-1 at the same dose Significant reductions in WOMAC pain scores a validated measure of knee pain and function More than 1 in 8 patients on retatrutide were completely free of knee pain by the end of the trial compared with less than 1 in 25 on placebo Significant improvements in physical function, stair climbing, and walking distance This matters clinically because knee osteoarthritis and obesity are deeply intertwined each kilogram of body weight lost reduces knee joint load by approximately 4 kilograms during walking
Clinical trial data from the STEP 1 extension study showed that after discontinuing semaglutide 2.4 mg, approximately two-thirds of weight loss was regained within one year
For some, its linked to constant nauseaimagine trying to work or parent while feeling seasick 24/7
Este tipo de medidas minimiza el riesgo de accesos indebidos y facilita recuperar la cuenta ante cualquier imprevisto
Kueh MT, Chew NW, Al-Ozairi E, le Roux CW